- Tytuł:
- Correction to: Vildagliptin Attenuates Huntington’s Disease Through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model
- Autorzy:
- Źródło:
- Neurotherapeutics: The Journal of the American Society for Experimental Neurotherapeutics. 19(2):686-686
Czasopismo naukowe